134197-98-1 Usage
Uses
Used in Pharmaceutical Industry:
(E)-3-(furan-2-yl)-N-methoxy-N-methylprop-2-enamide is used as a reagent in the pharmaceutical industry for its role in organic synthesis. Its potential bioactivity, including anti-inflammatory and anti-cancer properties, makes it a valuable compound in the development of new medications.
Used in Agrochemical Industry:
In the agrochemical industry, (E)-3-(furan-2-yl)-N-methoxy-N-methylprop-2-enamide is also utilized as a reagent in organic synthesis. Its contribution to the development of various agrochemicals highlights its versatility and importance in this sector.
Given the compound's potential bioactivity and applications, further research and development are essential to fully understand and harness its capabilities in these industries. Proper handling and safety measures are also crucial to ensure the safe and effective use of (E)-3-(furan-2-yl)-N-methoxy-N-methylprop-2-enamide.
Check Digit Verification of cas no
The CAS Registry Mumber 134197-98-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,1,9 and 7 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 134197-98:
(8*1)+(7*3)+(6*4)+(5*1)+(4*9)+(3*7)+(2*9)+(1*8)=141
141 % 10 = 1
So 134197-98-1 is a valid CAS Registry Number.
134197-98-1Relevant academic research and scientific papers
Manjunath, Beedimane Narayana,Sane, Neeraj P.,Aidhen, Indrapal Singh
, p. 2851 - 2855 (2006)
A new reagent for the synthesis of the α,β-unsaturated N-methoxy-N-methyl-amide structural unit has been developed. 2-(Benzo[d]thiazol-2-ylsulfonyl)-N-methoxy-N-methylacetamide, a crystalline solid with an indefinite shelf life that can be easily prepared in two convenient steps from 2-chloro-N-methoxy-N-methylacetamide, reacted with a variety of aldehydes under Julia conditions to furnish the α,β- unsaturated N-methoxy-N-methyl-amide functionality. Wiley-VCH Verlag GmbH & Co. KGaA, 2006.
